Ownership history in BARCLAYS PLC · 151 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in GLAXOSMITHKLINE PLC SPONSORED ADR (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,959 | -47,797 | -96.1% | 0.00% | $96K | $48.65 |
| 2025 Q3 | ADDED | 49,756 | +13,756 | +38.2% | 0.00% | $2.1M | $42.44 |
| 2025 Q3 | ADDED | 36,000 | +31,221 | +653.3% | 0.00% | $1.6M | $42.44 |
| 2025 Q2 | ADDED | 4,779 | +770 | +19.2% | 0.00% | $184K | $37.35 |
As of 2025 Q4 — sorted by position size